Biogen to reapply for Irish HSE funding for MS drug Fampyra

Dalfampridine, or Ampyra, is a potassium channel blocker that is shown to improve visual function, motor skills and relieve fatigue in MS patients.

Biogen to reapply for Irish HSE funding for MS drug Fampyra

Postby MSUK » Tue Jun 17, 2014 2:07 am

The makers of a drug that helps people with multiple sclerosis to walk are to make a fresh application to have it covered by the Health Service Executive-funded drug schemes. People with MS, who say Fampridine (known commercially as Fampyra) has greatly increased their mobility, have criticised the HSE for not reimbursing the cost of the drug on the long-term illness scheme...... Read More - http://www.ms-uk.org/ampyra
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2186
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Ampyra

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service